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A study of the association of cognitive 
abilities and emotional function with allergic 
disorders in young women
Mohammad Fereidouni1 , Hadis Rezapour2,3 , Mansoore Saharkhiz2,3 , Sara Mahmoudzadeh2,3 ,  
Malaksima Ayadilord2,3 , Masoumeh Askari2,4 , Samira Karbasi1,2 , Arefeh Abbaszadeh5 , 
Zahra Sadat Hoseini6 , Gordon A. Ferns7  and Afsane Bahrami1*  
Abstract 
Background: Allergic disorders may have a bidirectional causal relationship with mental disorders. In this cross-sec-
tional study, we aimed to assess the associations between cognitive abilities and emotional function tests and quality 
of life with the presence of allergic disease in young women.
Methods: A diagnosis of allergic disorders, comprising allergic rhinitis (AR), asthma and atopic dermatitis (AD), was 
confirmed by a specialist in allergy. The presence and severity of depression, anxiety, stress, insomnia and sleepiness 
were evaluated using validated questionnaires. Cognitive abilities and quality of life were assessed using standard 
instruments.
Results: Among 181 female young participants, the prevalence of AR, asthma and AD were 26.5%, 2.8%, and 14.9% 
respectively. The AR group had higher scores than the non-AR group for depression, anxiety, insomnia, and lower 
scores for physical and mental health-related quality of life. Moreover, the AD cases had higher scores on the depres-
sion and stress scale compared to those without it (p < 0.05). Asthmatic patients also had significantly higher insomnia 
severity and lower physical health-related quality of life than non-asthmatic.
Conclusion: There was a high prevalence of psychological/psychiatric disorders that included: anxiety, and sleep 
problems among allergic women, and a reduced quality of life that may be associated with it.
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Background
Atopy is a predisposition to mount an excessive immu-
nological response to a wide range of allergens, caus-
ing CD4 + Th2 differentiation and prolonged synthesis 
of immunoglobulin E (IgE). Atopy may arise through 
aberrant regulation by T helper cells and suppressor T 
lymphocytes that normally assist in the generation of IgE 
by plasma cells. The clinical effect of this is the propensity 
to develop hypersensitivity reactions to specific epitopes. 
Genetics and environmental factors contributed to the 
development of atopy [1].
There has been a steady rise in the prevalence of atopy 
in some countries, in particular allergic asthma, allergic 
rhinitis (AR), and atopic dermatitis (AD), in recent dec-
ades. Allergic disease is common globally, with different 
manifestations affecting more than half of the general 
population [2, 3]. Allergic rhinoconjunctivitis is a chronic 
IgE-induced inflammation in the nasopharynx with 
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typical manifestations include nasal congestion, rhinor-
rhea, sneezing, as well as itching [4].
Asthma is a chronic inflammatory disorders of the air-
ways described as a reversible airflow obstruction and 
bronchial hyper-sensitivity affecting 300 million people 
worldwide [5, 6]. Eczema is a pruritic chronic skin disor-
ders related to defective skin barrier extended immuno-
logical responses to environmental stimuli [7, 8].
It is possible that allergic disorders have a bidirec-
tional causal relationship with mental disorders [9]. For 
instance, psychiatric disorders are common among asth-
matics and are closely related to poor asthma control and 
quality of life [10]. Atopy-related conditions may cause 
psychological distress, which, in turn, may strengthen 
the manifestations of atopy. However, the reported rela-
tionship between atopy and psychological distress has 
been inconsistent. Mood and anxiety disorders, or major 
depressive disorder have been reported to be related to a 
higher risk of asthma [11–13]. A recent systematic review 
of 51 studies showed a significant relationship between 
AR and depression [14]. However, other reports found 
weak, or no associations, between anxiety or depression 
and atopy [15]. For instance, population-based studies in 
Australia and Asia demonstrated controversial findings 
regarding the association between AR and depression 
[16, 17]. In another study, anxiety was found to be associ-
ated with asthma and AR, but not with AD, and depres-
sion was not associated with any of these three atopic 
conditions [18].
Insomnia is defined as having difficulty falling asleep, 
maintaining sleep or having poor sleep quality despite a 
sufficient opportunity for sleep and together with day-
time symptoms i.e. fatigue, irritability, and lower concen-
tration. Sleep quality has been reported to differ between 
those with and without atopy [19, 20]. Health-related 
quality of life is a crucial patient outcome which evalu-
ates how a patient’s health influences physical or mental 
well-being. Several psychosocial and emotional factors 
may be related with poor control of atopic symptoms and 
may affect the quality of life, but they have received little 
attention.
Psychiatric comorbidities may, however, exacerbate or 
inhibit symptom perception in chronic atopy. They may 
affect the pathophysiology of atopic disorders via down-
stream effects on the central nervous system (CNS), via 
the hypothalamic–pituitary–adrenal (HPA) axis that 
causes a cytokine response, that leads to a chronic pro-
inflammatory state [21].
Cognitive impairment, depression, anxiety, stress, and 
sleep problems are common and important psychological 
disorders, but studies that have evaluated the association 
between these complications in the allergic cases have 
been inconsistent particularly in women. Female sex has 
previously been reported to be related with worse allergy 
control and worse allergy-related quality of life as well as 
increased rates of health care visits, and medication use 
[22, 23]. Hence, the purpose of the present study was 
to evaluate associations between cognitive abilities and 
emotional function tests and quality of life with the pres-




This cross-sectional study was performed in a group of 
female students in the city of Birjand, in eastern Iran, 
between December 2019–January 2020 [24]. Participants 
were chosen from 5 different universities in Birjand, 
using a multistage cluster sampling method. The sample 
size was calculated to achieve 80% power and α′ = 0.05 
using data from a previous investigation [25]. To limit 
heterogeneity and control for potential confounding fac-
tors, only unmarried, apparently healthy women, aged 
between 18 and 25  years were recruited. The exclusion 
criteria included: the presence of any acute or chronic 
systemic disorders and taking any medication. The Eth-
ics Committee of Birjand University of Medical Sciences 
approved the study (Code: 4891). All study participants 
gave written informed consent.
Phenotypic characterization of allergic conditions
Diagnosis of allergic disease was performed by same spe-
cialist in allergy, by assessment of clinical history, physi-
cal examination, skin-prick testing (SPT) and laboratory 
assessment in allergy and immunology clinic. SPT for 
common allergens was conducted by an expert immu-
nologist with standard protocols as described previously 
[26]. Non-allergic groups were participants having nei-
ther allergic sign/manifestations nor any sensitivity to 
allergens in the SPT. Total serum IgE levels were quan-
tified by using an Elisa kit (Euroimmun, Germany) in 
accordance with the manufacturer’s protocols.
Evaluation of cognitive abilities
Cognitive performance was assessed using the Cogni-
tive Abilities Questionnaire (CAQ). This questionnaire 
includes 30 items which are rated from 1 to 5 to yield a 
total score ranging from 30 to 150. Higher scores imply 
better cognition performance. The CAQ evaluates seven 
abilities task including memory (6 items), inhibitory 
control and selective attention (6 items), decision mak-
ing (5 items), planning (3 items), sustained attention (3 
items), social cognition (3 items) and cognitive flexibility 
(4 items) [27].
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Assessment of depression, anxiety and stress
Depression anxiety and stress scale (DASS-21) is a most 
commonly used, valid and reliable instrument for evalu-
ating negative emotions. This questionnaire comprises 
21-items with 3 sub-scales in which each items is rated 
on a 4-point Likert scale (0–3) measuring depression, 
anxiety and stress. Because the DASS-21 is the brief ver-
sion of DASS-42; the total score of each subscale must be 
doubled [28, 29]. Higher score related with severe nega-
tive emotions. The reliability and validity of DASS-21 
for Iranian population was approved previously [29, 30]. 
Depression, anxiety, and stress scores were divided into 
two categories (No/Minimal state and some degree of 
disorder) according to the scores obtained for each sub-
scale as follows: No (≤ 9) or some degree of depression 
(> 9); No (≤ 7) or some degree of anxiety (> 7); and No 
(≤ 14) or some degree of stress (> 14).
Quality of life
The Short Form-12 Health Survey (SF-12) derived from 
the SF-36 is one of the most popular generic instrument 
for measurement of physical and mental components 
of quality of life [31]. The SF-12 consists of twelve ques-
tions covering 8 domains of personal health which higher 
scores represented better health related quality of life. 
The Persian version of SF-12 which has good reliability 
and validity for Iranian population was used in this study 
[32]. A score below the median cut off for the QoL score 
was considered to be a low QoL.
Assessment of sleep pattern
Insomnia severity
The ISI was first developed by Morin et al. and has been 
used extensively in the last decades [33]. The ISI is a 
seven-item self-reported questionnaire measuring the 
nature, severity of insomnia and associated sleep prob-
lems such as sleep dissatisfaction. A 5-point Likert scale 
is used to score each question (0 = No, to 4 = very severe), 
providing a sum score between 0–28. Based on acquir-
ing scores, individuals were categorized as: no clinically 
significant insomnia (0–7), or mild to severe degree of 
insomnia (8–28). The Persian version of the ISI has good 
reliability and validity for Iranian population was used in 
current study [34].
Sleepiness severity
The Epworth sleepiness scale (ESS) is an 8-item self-
reported questionnaire to evaluate the average degree 
of daytime sleepiness propensity. Each item rated on 
4-point Likert scale (0–3) to measures the habitual like-
lihood to fall asleep in eight daily life conditions [35]. 
Higher scores of the ESS reflected a greater average 
tendency to fall asleep. Normal values range from 0 to 10, 
score of 10–16 indicated mild to moderate sleepiness and 
more than 16 defined to severe sleep apnea or narcolepsy 
[36].
Assessment of covariates
Demographic and anthropometric variables including: 
age, height, weight, waist and hip circumference were 
gathered by an expert nurse. Then, body mass index 
(BMI) was calculated as weight (kg) divided to height 
2(m). Waist-to-hip ratio (WHR) was obtained by dividing 
waist circumference by hip circumference. Dietary intake 
of participants was gathered by a valid and reliable semi 
quantitative food frequency questionnaire (FFQ) consist-
ing 65 food items in order to estimation of dietary intakes 
of subjects [37, 38] and then energy intake for each of 
them was estimated.
Statistics
All of variables were normally distributed by using Kol-
mogorov–Smirnov test (p value for cognitive abili-
ties, depression, anxiety, stress, quality of life, insomnia 
and sleepiness was 0.09, 0.051, 0.067, 0.21, 0.18, 0.052, 
0.61) and were analyzed by applying parametric statis-
tical tests. Parametric and non-parametric continuous 
variables as well as categorical indices demonstrated 
by Mean ± Standard deviation (SD), median and inter-
quartile range (non-parametric variables), and number 
(percent), respectively. Independent sample T-test or 
Mann–Whitney test was used for comparison of contin-
uous variables between 2 groups. Regression analysis was 
used to evaluate the predictive value of having allergy for 
emotional complications (as the dependent variables). 
In the analysis, anxiety and insomnia were divided into 
two categories (no/minimal status or some degree of dis-
order) regarding the scores and individuals in the first 
group (no/minimal status) were set a reference group. 
Then, binary logistic regression analyses were recruited 
to estimate the odds, as showed by the odds ratio (OR). A 
p < 0.05 was considered to be statistically significant. All 
of analysis performed by using SPSS for Windows version 
16.0.
Results
One hundred and eighty-one female students, between 
18 and 27 years of age (mean: 20.7 ± 2.2 y) were recruited 
to this study. Among the 181 participants, fifty four 
(29.8%) individuals had at least one type of allergic dis-
ease. In total, AR, asthma and AD were present in 
48(26.5%), 5(2.8%) and 27 individuals (14.9%), respec-
tively. One hundred and twenty-seven (70.2%) individuals 
did not have any allergic disorders and were considered 
as non-allergic cases. Demographic characteristics of 
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study participants were shown in Table  1. Allergic and 
non-allergy groups had similar mean age, BMI and WHR 
(p > 0.05). But, serum IgE levels significantly increased in 
atopy cases (p = 0.001).
Allergic cases had higher anxiety and insomnia scores, 
and lower mental health related quality of life scores 
compared to those without any allergy (p < 0.05; Table 2). 
No significant difference was found between atopy and 
non-atopy groups in terms of cognitive abilities tasks 
(p > 0.05).
Sub-group analysis of the association between emo-
tional function tests with different allergic disorders is 
shown in Table  3. The AR group scored less well than 
the non-atopic group on the DASS-21 test (depressed 
mood and anxiety behaviors), insomnia severity, as 
well as physical and mental health-related quality of life 
(p < 0.05). Additionally, the AD group obtained a higher 
score on the depression and stress scale compared to 
those without it (p < 0.05). Asthmatic patients also have 
significantly higher insomnia severity and lower physical 
health-related quality of life than non-asthmatic patients.
Binary regression analysis was performed to assess the 
relationship of having allergy and emotional complica-
tions. In logistic regression analyses adjusted for poten-
tial confounders, individuals that did not have allergy 
served as a reference group (Table 4). Those with at least 
one allergy disorders were more likely than healthy indi-
viduals to have anxiety behavior (OR = 1.86, 95% confi-
dence interval [CI]:1.02–3.4), and insomnia symptoms 
(OR = 2.3; 95% CI 1.2–4.3).
Table 1 Demographic characteristics of study participants
Data presented as Mean ± SD (parametric variables) or median and interquartile 
range (non-parametric variables). By using independent sample t-test or Mann–
Whitney test
The significance of bold values is P < 0.05
BMI body mass index, WHR waist-to-hip ratio, IgE immunoglobulin E







Age (year) 20.6 ± 1.4 21.1 ± 2.0 0.06
BMI (kg/m2) 20.8 ± 3.0 20.8 ± 2.8 0.98
WHR 0.74 ± 0.04 0.73 ± 0.04 0.82
IgE (U/mL) 151.6(53.7–402) 37.9(11.5–253) 0.001
Table 2 Association between neuropsychological tests with different allergic disorders
Data presented as Mean ± SD. By using independent sample t-test
Bold values are remained significant even after bonferroni corrections






Memory 25.3 ± 3.4 25.7 ± 3.5 0.39
Inhibitory control and selective attention 21.7 ± 4.1 22.2 ± 3.8 0.38
Decision making 18.7 ± 3.4 19.1 ± 4.0 0.43
Planning 10.7 ± 2.9 11.5 ± 2.7 0.07
Sustain attention 9.4 ± 2.4 9.6 ± 2.4 0.69
Social cognition 10.6 ± 2.0 10.7 ± 2.2 0.38
Cognitive flexibility 14.6 ± 2.7 14.4 ± 2.9 0.63
Total cognitive ability task 110.9 ± 13.6 113.3 ± 14.9 0.27
Dass-21
Depression 12.1 ± 9.4 9.5 ± 7.9 0.06
Anxiety 9.9 ± 6.7 7.4 ± 5.3 0.009
Stress 17.8 ± 10.0 16.8 ± 9.9 0.52
Quality of life
Physical health 15.5 ± 2.6 16.2 ± 2.4 0.06
Mental health 15.9 ± 3.5 17.1 ± 3.9 0.036
SF-12 score 31.5 ± 5.0 33.4 ± 5.0 0.018
Sleep pattern
Insomnia score (ISI) 7.3 ± 6.9 4.5 ± 6.3 0.006
Daytime sleepiness score (ESS) 6.7 ± 6.0 5.8 ± 5.7 0.31
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Discussion
This is the first study that has investigated the associa-
tion between cognitive abilities and emotional function 
and different allergic disorders in young women. In this 
cross-sectional study, we found that women who have 
any allergy have a greater degree of anxiety and insomnia, 
and have lower mental quality of life compared to those 
without it. Specifically, individuals with AR have higher 
depression, anxiety, insomnia and lower both mental and 
physical health score of quality of life; AD cases obtained 
a higher score on the depression and stress; and asth-
matic patients also have significantly higher insomnia 
severity and lower physical health-related quality of life 
scale compared to those without it.
AR is not only a nasal problem but also leads to a wide 
spectrum of manifestations, some of which may lead to 
depression, anxiety, and insomnia problems related to 
reductions in mental and physical aspects of quality of 
life. AR is not only limited to the physical symptoms of 
the nose and eyes but also exacerbates disturbances in 
the well-being of the affected individuals.
Our findings are in accord with previous studies 
that have demonstrated that the depression risk in AR 
patients is higher than patients without AR [14, 39, 40]. It 
has been shown that the severity of depression was asso-
ciated to disease activity and was even more profound 
when atmospheric pollen is high in individuals with sea-
sonal AR [41]. AR patients most frequently suffer from 
sleep disturbances [42]. Among the several mechanisms 
influencing sleep quality/quantity, nasal congestion is 
an important feature. Resistance to air flux through the 
nasal airway causes a risk of sleep respiratory complica-
tions i.e. apnea or snoring [43].
Our results support previous findings that disturbed 
sleep and reduced health-related quality of life due to the 
physical and psychological impairments in AR patients 
[44, 45]. There is accumulating evidence indicating that 
individuals with AR have impaired psychological health 
and that these usually go undetected/untreated, and thus 
may causes mental distress [46–48]. AR symptoms such 
as ocular symptoms and nasal congestion can signifi-
cantly disturb health-related quality of life and may make 
adults and children vulnerable to different comorbid con-
ditions, which may further impair the quality of life [49].
In our population sample, 14.9% had eczema which 
was associated with greater levels of depression, and 
stress compared to those without it, and this is consist-
ently supported in other studies [50, 51]. In a recent sys-
tematic review and meta-analysis, patients with eczema 
had a higher risk of depression. Increased duration and 
frequency of eruptions, as well as the increment in sick 
leave, were associated with higher psychological disor-
ders [51].
Table 3 Association between cognitive abilities and emotional function tests with different allergic disorders
Data presented as Mean ± SD
By using independent sample t-test
Bold values are remained significant even after bonferroni corrections















Depression 12.3 ± 9.6 9.2 ± 7.5 0.021 14.1 ± 9.7 10.2 ± 8.3 0.035 15.6 ± 9.3 10.8 ± 8.8 0.23
Anxiety 10.1 ± 6.9 7.4 ± 5.2 0.005 10.0 ± 8.0 8.6 ± 5.9 0.27 12.0 ± 8.2 8.8 ± 6.2 0.26
Stress 17.9 ± 10.1 16.7 ± 9.8 0.45 21.0 ± 11.2 16.6 ± 9.6 0.037 23.4 ± 6.5 17.2 ± 10.0 0.17
Quality of life
Physical health 15.4 ± 2.6 16.2 ± 2.4 0.04 15.9 ± 2.4 15.8 ± 2.4 0.79 12.2 ± 4.4 15.8 ± 2.4 0.001
Mental health 15.8 ± 3.5 17.2 ± 3.8 0.011 15.9 ± 3.9 15.8 ± 2.4 0.41 14.2 ± 3.0 16.4 ± 3.7 0.18
SF-12 score 31.4 ± 5.0 33.5 ± 4.9 0.006 31.9 ± 5.5 32.4 ± 5.0 0.61 29.2 ± 3.0 32.3 ± 5.1 0.23
Sleep pattern
Insomnia score (ISI) 7.4 ± 6.9 4.5 ± 6.3 0.005 6.0 ± 7.1 6.1 ± 6.6 0.96 13.6 ± 10.1 6.0 ± 6.7 0.015
Daytime sleepiness score (ESS) 6.8 ± 6.1 5.8 ± 5.7 0.20 6.4 ± 6.1 6.2 ± 5.9 0.85 9.4 ± 6.7 6.2 ± 5.9 0.23
Table 4 Logistic regression analysis of having any allergy as 
a predictor of anxiety behavior, low quality of life as well as 
insomnia
Odds ratios with 95% confidence intervals (95% CI) obtained from binary logistic 
regression tests. Adjusted for age, BMI and energy intake
Anxiety behavior Low quality of life Insomnia 
symptom
No-allergy Ref Ref Ref
Having allergy 1.86(1.02–3.4) 1.75(0.88–3.48) 2.3(1.2–4.3)
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Our results showed that asthmatic patients had a 
higher level of insomnia symptoms and lower physi-
cal health quality of health. The prevalence of insom-
nia among asthma patients varied from 10 to 70% in 
different population [52, 53]. Our results strengthen 
previous findings reported in asthmatic patients in 
which sleep disturbance was linked with lower disease-
specific quality of life. Sleep problems are commonly 
related to an effect of nocturnal awakenings because of 
the nighttime asthma symptoms or the requirement for 
rescue inhaler medication [54, 55].
Other factors may also participate in the evolution 
of insomnia in asthmatic patients. Predisposing causes 
elevate the subject’s susceptibility to develop insom-
nia including personality characteristics i.e. anxiety or 
hyper-arousal, or genetic reasons such as female gen-
der, aging, or family history [56]. Precipitating factors 
(stressful life events and health/psychological compli-
cations) can stimulate the onset of insomnia.
We have also shown that individuals who have at least 
one allergy suffer from higher anxiety and insomnia 
symptoms, and have lower mental health related qual-
ity of life. Multiple mechanisms have been suggested to 
explain allergies can affect mood. There may be somatic 
alterations such as discomfort induced by allergic 
inflammatory processes throughout the upper airway, 
which may influence well-being. This condition may 
causes to other possible mediators influencing mood, 
such the administration of medications (i.e. vasocon-
strictors and antihistamines) or interfering with sleep 
induced by several factors such as airways obstruction 
[57, 58]. The release of cytokines as an inflammatory 
mediators possibly triggers mood worsening through 
direct action on the brain or via indirect other path-
ways such as interplays with the HPA axis and the IDO 
enzyme. It has been found that cytokines can promote 
anxiety and depression. Additionally, allergic symptoms 
have been related with the levels of cytokines released 
within some allergic responses [59]. Nevertheless, to 
the best of our knowledge, few studies evaluate the 
association of cognitive performances and symptom 
of allergic disorders; hence, this study provides worth 
information in this context. The results of the present 
study are consistent with those of previous research 
that has indicated that asthma, AR and AD does not 
alter cognitive abilities or practical IQ [60, 61].
This study has several limitations. It is a cross-sec-
tional study, so it is not possible to conclude anything 
about the direction of the causation or the mechanism 
behind the relationship between allergy and depression. 
Future large longitudinal studies should be performed 
to support these findings and an investigation of the 
mechanisms attributed to this reported association. 
Notably, all of cognitive abilities and emotional func-
tion tests was measured only for the past 12  months, 
rather than lifetime.
Conclusions
The results of present study showed that there was a 
high prevalence of psychological and psychiatric dis-
orders such as anxiety, sleep problems as well as lower 
quality of life among allergic patients. Regarding the 
high prevalence of psychological problems in atopic 
patients, careful evaluation and treatment of these co-
morbidities should be considered in patients visit.
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